Mountain View, California, USA
Chicago, Illinois, USA
Gothenburg, Sweden

Our Story

In June 2010, our founders conceived the idea behind Glooko because each of them was personally touched by diabetes in a significant way. They set out to seamlessly release diabetes data so that insights could be delivered to both people with diabetes and their care teams, and thereby transform the way daily decisions are made by leveraging the power of mobile, cloud and analytics.

Since then, Glooko has become an innovative international company with offices in Silicon Valley, Chicago and Sweden that provides a unified platform for diabetes management. We strive to improve health outcomes for people with diabetes and reduce costs associated with diabetes management. Glooko is dedicated to bringing innovation to diabetes management around the world.

The Glooko team has a passion for creating great software and tools for easier diabetes management. Through hard work and fun times, we pridefully bring you Glooko.

Leadership Team

Russ Johannesson

Chief Executive Officer

Komathi Stem

Chief Operating Officer

Zach Henderson

Chief Commercial Officer

Mark Clements, M.D., Ph.D.

Chief Medical Officer

Stephen Lien

Chief Financial Officer

Kyle Brown

Chief Technology Officer

David Conn

Executive Vice President of Partnerships & Alliances

Anders Sonesson

General Manager EMEA/APAC

Board of Directors

Our board of directors is made up of industry leaders and founders that supports, advises and enables Glooko to be the leading unified platform for diabetes management.

Simon Chong

Co-Founder and Managing Partner, Georgian Partners / Board Member

Yogen Dalal

Founder, Glooko / Board Member

Russ Johannesson

Chief Executive Officer, Glooko / Board Member

Wende Hutton

General Partner, Canaan Partners / Board Member

Tracy Bahl

OneOncology, CVS, General Atlantic, Emdeon, UHG / Board Member

Mike Doherty

Foundation Medicine, Genentech, Roche, AZ, RPR, Sandoz / Board Member

Charles Boorady

Founder & Managing Partner, Health Catalyst Capital / Board Member

Medical Advisory Board

Mark Clements, M.D., Ph.D.

Glooko Chief Medical Officer, Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Pediatric Endocrinologist, Children's Mercy Kansas City

Jerome Fischer, M.D.

Partner, Diabetes and Glandular Disease (DGD) Clinic

Michael Greenfield, M.D.

Endocrinologist, El Camino Hospital

David Kerr, M.D.

Director of Diabetes Research and Innovation, Sansum Diabetes Research Institute

Join the Glooko team

See Open Positions